This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Ramipril cost effective for cardiovascular risk reduction. Pharmacoecon. Outcomes News 316, 5 (2001). https://doi.org/10.1007/BF03269375
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269375